Peripheral Blood Mononuclear Cell Therapy for the Treatment of Lower Limb Ischemia in Diabetic Patients: Is It Really True?

Ann Vasc Surg. 2019 Apr:56:359-360. doi: 10.1016/j.avsg.2018.10.010. Epub 2018 Nov 23.

Authors

Eugenio Caradonna¹, Carlo Maria De Filippo², Piero Modugno², Nicola Testa², Emilio Vanoli³, Mariangela Amatuzio², Michelangelo Farina⁴, Enrico Maria Centritto²

Affiliations

¹ Department of Cardiovascular Medicine, Fondazione di Ricerca e Cura Giovanni Paolo II, Campobasso, Italy. Electronic address: eugenio.caradonna@fgps.it.
² Department of Cardiovascular Medicine, Fondazione di Ricerca e Cura Giovanni Paolo II, Campobasso, Italy.
³ Department of Molecular Medicine, University of Pavia, Pavia; Department of Cardiovascular Diseases IRCCS Multimedica, Sesto San Giovanni, Italy.
⁴ By Invitation.

PMID: 30476611
DOI: 10.1016/j.avsg.2018.10.010

No abstract available

Publication types

Letter
Comment

MeSH terms

Cell- and Tissue-Based Therapy
Diabetes Mellitus*
Humans
Ischemia
Leukocytes, Mononuclear*
Treatment Outcome